On 7 September 2021 KIELTYKA GLADKOWSKI will take part in the Webinar Analysing the Role of Telemedicine in Post-Pandemic Care organised by Reuters Events in conjunction with the Digital Health division of the World Health Organisation which provides opportunities to accelerate progress in attaining health and well-being related Sustainable Development Goal (SDGs), especially SDG 3, and achieving triple billion targets for 2023 as articulated in its Thirteenth General Programme of Work (GPW13).

The webinar will focus on the growing importance of remote telemedicine, its aspects and opportunities. The speakers will include:

– Peter Thomas, CCIO and Director of Digital Medicine at Moorfields Eye Hospital

– Toralf Schnell, Chief Digital Officer and Head of the Digitization Unit at University Medicine Greifswald

– Dr. Evgeny Zheleznyakov, Technical Officer, WHO European Centre for Primary Health Care.

Telemedicine and digital health remains in the core specialisation of lifescience and healthcare expertise of KIELTYKA GLADKOWSKI, having vast experience in handling projects at the intersection of new technologies and healthcare, including data protection, regulatory and transactional aspects.

More

On 2 to 4 November 2021 KIELTYKA GLADKOWSKI KG LEGAL will take part in the virtual SPG 2021 Forum organised by R3 (Association of Business Recovery Professionals) SPG Forum (link) is a conference for trustees, restructuring experts and their employees.

During this 3-day event, our lawyers will have the opportunity to discuss the practical issues, participate in workshops and network with peers.

Some of the topics discussed will be the current regulatory framework for insolvency practitioners, key legal changes affecting the insolvency and restructuring of people and companies, and the exclusion of directors, the FCA’s guidelines for managers appointed or intended to be appointed by regulated firms; panel sessions with representatives of the financial industry discussing their experiences with the pandemic, recovery and new market trends; workshops, during which it will be possible to look at issues related to the insolvency of a real estate enterprise; workshop sessions during which the investigation and prosecution of claims in insolvent real estate will be discussed in-depth; interactive workshops, entirely devoted to the possibilities of the hotel business dealing with the challenges of the pandemic.

More

On 29 July 2021 KIEŁTYKA GŁADKOWSKI KG LEGAL took part in the webinar ‘Cell and gene data innovation and multi-stakeholder data transfer’ (Plan, capture and set the infrastructure for data sharing across the value chain, to optimize commercial strategy), organized by Reuters Events in participation and partnership with Salesforce. The scope of the webinar is within life science and digital health specialization that constitutes one of the core specializations of our law firm.

Some of the panelists included:

Augusto Penjasoff – Business Partner, Global Cell Therapy IT Head in BMS (Bristol Myers Squibb),

Curt Fitzgerald – Director- Service Delivery- C&GT in Novartis,

Gary Gabriel – Global Advisor for Healthcare and Life Sciences in Tableau,

Neary Detrick – Senior Director, Data Management & Analytics in Bluebird Bio,

and Beth Hayes as a moderator- healthcare and lifesciences business consulting – Pharma Lead, Industry Transformation (Salesforce).

The mission of Salesforce company (a partner and a participant of the webinar) is to empower companies to connect with the customers, providers of services and patients in the new and reimagined way. Salesforce serves leading organizations across the industry, including pioneers in CGT (cell and gene therapy).

Important question posed during the webinar concerned personalized medicine.

The response is that the latter is the future of the medicine (so-called a Medicine 2.0). A deliberation about personalized medicine is not a discussion about future in about 10 or 15 years. It drives a magnificent impact across the industry. There was also discussed the question of the difference between the traditional medicine and personalized medicine.

More

Brand New Online Portal of the Polish Register of Entrepreneurs of the National Court Register

On 1^st July 2021 in Polish jurisdiction a revolutionary change has taken place. Namely, there has been amended an Act on the National Court Register (Journal of laws of 2021, item 112 as amended).[1] The amendment is about an introduction of an electronic registration procedure. Especially the form of filing applications for the entry in the Register of Entrepreneurs of the National Court Register will be changed.[2] The amendment mainly concerns the registration issue of the limited liability company and the partnerships.

The National Court Register Act amendment is caused by a necessity to implement the European Parliament directives and the EU’s Council directives on some of the company law aspects (2017/1132 EU; 2012/17/ EU, etc.).[3] The issue of the adaptation to the European Union law can be found in the first article (art.1) of the Amendment Act of the National Court Registration Act.

More

SECOND PART- TRENDS AND DEVELOPMENT OF SPECIFIC TELEHEALTH SECTORS

Sectoral legal advice for clients from the telemedicine sector requires from lawyers to constantly monitor the market in this sector and constantly expand their knowledge of market needs. It is the duty of every lawyer of KIEŁTYKA GŁADKOWSKI to be up-to-date with the sector of economic activity on which they provide legal services. Proper legal advice requires from lawyers to know the market practice of a given sector, and above all, knowledge of complex IT terminology and the basics of the pharmaceutical market.

I Telehealth trends’ perspectives

On the Telehealth Investment Trends we can have a look from different perspectives.

1. One of these perspectives is a funding perspective. In the 2^nd quarter of 2021 we can notice a funding record broken for the 4^th quarter in a row (from the 3^rd quarter of 2020). The deal count amounted 163 deals and the funding amounted 5,038 (in millions of dollars).
2. The continental differences. It is explicitly noticeable that European investment nearly quintupled QoQ to reach a record high of $915M. Asian investments almost halved, north American investment slightly increased but European made an incredible investment growth which might be a long-perspective tendency (especially regarding the COVID-19 pandemic and Europe’s ageing an increasingly digitalized society). Among these reasons and investment tendencies the polish executive in the abovementioned ordinance included the procedures to impart instructions about e- medical prescription realization, additional treatment, tests realization (including laboratory tests) and possibility to sign up an Online Patient Account[1]. These procedures and medical services requirements can be (and in deed will be for sure) unquestionably helpful for older people who are yet to learn with increasingly used IT systems.
3. The differences between early-, mid- and late- stage deal percentage. It is worthy to notice that in the 2021 early-stage deal share tracked at a historical low but at the same time the late-stage share at its high level (12% in comparison to previous 8%). This may reflect the increasing sophistication and maturity of the telehealth industry and of course the maturity and investment development and advancement of telehealth entities.

More